QQ客服 官方微博 反馈留言

	Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor
	Wang Hui-Jing[1]; Gu Han-Xin[2]; Eijkelkamp Niels[3]; Heijnen Cobi J[4]; Kavelaars Annemieke[5]
刊名	Frontiers in pharmacology
	2018
卷号	9页码:592
关键词	ESI-09 Epac GDNF GRK2 HSV vector hyperalgesic priming
ISSN号	1663-9812
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2175257
专题	上海大学
作者单位	1.[1]Laboratory of Neuropsychopharmacology, College of Fundamental Medicine, Shanghai University of Medicine & Health Science, Shanghai, China. 2.[2]Laboratory of Neuropsychopharmacology, College of Fundamental Medicine, Shanghai University of Medicine & Health Science, Shanghai, China. 3.[3]Laboratory of Neuroimmunology and Developmental Origins of Disease, University Medical Center Utrecht, Utrecht, Netherlands. 4.[4]Division of Internal Medicine, Laboratory of Neuroimmunology, Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 5.[5]Division of Internal Medicine, Laboratory of Neuroimmunology, Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
推荐引用方式 GB/T 7714	Wang Hui-Jing[1],Gu Han-Xin[2],Eijkelkamp Niels[3],et al. Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor[J]. Frontiers in pharmacology,2018,9:592.
APA	Wang Hui-Jing[1],Gu Han-Xin[2],Eijkelkamp Niels[3],Heijnen Cobi J[4],&Kavelaars Annemieke[5].(2018).Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.Frontiers in pharmacology,9,592.
MLA	Wang Hui-Jing[1],et al."Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor".Frontiers in pharmacology 9(2018):592.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。